Since its introduction more than 2 decadesago,endovascularaneurysmrepair(EVAR)hasplayed an increasing role in the managementof abdominal aortic aneurysm (AAA). Accord-ingly, well-known randomized controlled trialshavebeenconductedtodescribetheearly-andlong-term results of EVAR using first- andsecond-generation aortic endografts.